 I27.2 |
 |
Other secondary pulmonary hypertension |
| |
| CodeAlso |
associated underlying condition
|
| Excludes1 |
Eisenmenger's syndrome (I27.83)
|
|
| |
 I27.20 |
|
Pulmonary hypertension, unspecified |
| |
| Pulmonary hypertension NOS |
|
|
| |
| I27.21 |
|
Secondary pulmonary arterial hypertension |
| |
| (Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS | | (Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension |
| CodeAlso |
associated conditions if applicable, or adverse effects of drugs or toxins, such as:
adverse effect of appetite depressants (T50.5X5)
congenital heart disease (Q20-Q28)
human immunodeficiency virus [HIV] disease (B20)
polymyositis (M33.2-)
portal hypertension (K76.6)
rheumatoid arthritis (M05.-)
schistosomiasis (B65.-)
Sjögren syndrome (M35.0-)
systemic sclerosis (M34.-)
|
|
|
| |
| I27.22 |
|
Pulmonary hypertension due to left heart disease |
| |
| Group 2 pulmonary hypertension |
| CodeAlso |
associated left heart disease, if known, such as:
multiple valve disease (I08.-)
rheumatic mitral valve diseases (I05.-)
rheumatic aortic valve diseases (I06.-)
|
|
|
| |
| I27.23 |
|
Pulmonary hypertension due to lung diseases and hypoxia |
| |
| Group 3 pulmonary hypertension |
| CodeAlso |
associated lung disease, if known, such as:
bronchiectasis (J47.-)
cystic fibrosis with pulmonary manifestations (E84.0)
interstitial lung disease (J84.-)
pleural effusion (J90)
sleep apnea (G47.3-)
|
|
|
| |
| I27.24 |
|
Chronic thromboembolic pulmonary hypertension |
| |
| Group 4 pulmonary hypertension |
| CodeAlso |
associated pulmonary embolism, if applicable (I26.-, I27.82)
|
|
|
| |
| I27.29 |
|
Other secondary pulmonary hypertension |
| |
| Group 5 pulmonary hypertension | | Pulmonary hypertension with unclear multifactorial mechanisms | | Pulmonary hypertension due to hematologic disorders | | Pulmonary hypertension due to metabolic disorders | | Pulmonary hypertension due to other systemic disorders |
| CodeAlso |
other associated disorders, if known, such as:
chronic myeloid leukemia (C92.10-C92.22)
essential thrombocythemia (D47.3)
Gaucher disease (E75.22)
hypertensive chronic kidney disease with end stage renal disease (I12.0, I13.11, I13.2)
hyperthyroidism (E05.-)
hypothyroidism (E00-E03)
polycythemia vera (D45)
sarcoidosis (D86.-)
|
|
|
